USPTO serial 79382747
PHAEOSYNT
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BIBB, SCOTT
- Law office
- TMEG LAW OFFICE 109
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with PHAEOSYNT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert S. Broder
Robert S. Broder Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical and veterinary use; pharmaceuticals for antibody therapy and enzyme therapy; diagnostic agents for medical purposes; diagnostic substances for medical use; medical diagnostic reagents; antibodies for medical purposes; antibodies for medical purposes, namely, diagnostic antibodies; dietary supplements and dietetic preparations adapted for medical purposes; protein dietary supplements; pregnancy test kits for home use, professional use, clinical use and medical use; diagnostic reagents for medical use; drug testing kits containing primarily medical diagnostic reagents and assays for testing body fluids; specimen collection kits for use in pathogen testing comprised primarily of swabs for medical purposes and also including buffer for sample application, plastic bags for transmitting medical specimens, printed mailing labels, plastic bags for the disposal of potentially infectious material; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, stool sample analysis, lacrimal fluid analysis; diagnostic biomarkers for in vitro testing for medical use, siccatives being drying agents for medical purposes; therapeutic pharmaceuticals for antibody treatments | ACTIVE | — |
| 010 | Medical and veterinary apparatus, instruments, namely, surgical apparatus and instruments for medical and veterinary use, medical and surgical equipment used during medical and surgical procedures; surgical apparatus and instruments for veterinary use; medical and veterinary articles, namely, diagnostic test kits and enzyme-linked immunosorbent assay microplates and plasticware, equipment for detection procedures for blood analysis, urine analysis, saliva analysis, stool sample analysis, lacrimal fluid analysis; diagnostic, examination, and monitoring equipment namely, test kits for blood sugar levels, pathogen infections, hormone and nutrient levels; medical diagnostic apparatus for testing blood sugar levels, pathogens, hormone and nutrient levels; diagnostic equipment and apparatus namely, immunoassays; diagnostic measuring apparatus for medical use namely, analyzing and measuring hormone, nutrient and enzyme levels in the body; medical diagnostic apparatus for pregnancy testing; tools for medical diagnostics to examine pathogens, hormone, nutrient and enzyme levels; capillary tubes for samples for medical use; medical devices for obtaining body fluid samples | ACTIVE | — |
| 042 | Scientific laboratory services; scientific and technological services, namely, research and design in the field of phage display and protein production; medical research; natural science services, namely, protein production and assay development; research and development services in the field of antibody technology; research services in the field of proteins, antibodies, microorganisms and cells, development in the field of proteins, antibodies and microorganisms and cells; medical research laboratory services relating to the production of antibodies; laboratory testing of materials; biological analysis in the field of molecular biology; design and development of medical diagnostic apparatus; biomedical research services; research services and development services in the field of antibody and protein discovery and production; research laboratories; scientific laboratory services in the field of antibody and protein assay development; diagnostic preparation of biological samples for analysis in research laboratories | ACTIVE | — |
| 044 | Medical services; medical laboratory services relating to the treatment of persons for the analysis of samples taken from patients; medical diagnostic services namely, medical testing and analysis; disease diagnosis services; medical screening; medical analysis services for diagnostic purposes provided by medical laboratories; medical and healthcare services; medical laboratory services for the analysis of samples taken from patients | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Phaeosynt GbR
- Other trademarks owned by Phaeosynt GmbH
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PHAEOSYNT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 12, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 12, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 12, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 26, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 8, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 20, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 22, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |